Drug Discovery

 Drug Discovery
 

Neurodegenerative diseases such as Parkinson's and Prion Diseases are associated with the accumulation of fibrillar proteins. The unifying feature of a fibril formation is the structural transition from an initial globular or intrinsically disordered state to a β-structural form. Using advanced computational and experimental molecular biology tools,  we are identifying  chemicals which affect fibril formation  and interfere with the diseases.

written by Paolo Carloni This e-mail address is being protected from spambots. You need JavaScript enabled to view it. , image by Xevi Biarnes This e-mail address is being protected from spambots. You need JavaScript enabled to view it.